1:1, 2:1 or 3:1 complex consisting of a cyclodextrin or cyclodextrin derivative and a halogenated ether, production therof and use therof as soporific

Complex (A) of a cyclodextrin or its derivative and a low molecular weight halogenated ether in a molar ratio of 1:1 or 2:1 or 3:1, is new. Independent claims are included for: (1) the preparation of (A); and (2) a pharmaceutical formulation that is liquid or solid under normal conditions, comprisin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SIGL, HARALD, BUSOLD, MARKUS, MITTERWEGER, SIMONE, REGIERT, MARIA-ELISABETH
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY COMPOSITIONS BASED THEREON DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC MACROMOLECULAR COMPOUNDS POLYSACCHARIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES THEIR PREPARATION OR CHEMICAL WORKING-UP
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Complex (A) of a cyclodextrin or its derivative and a low molecular weight halogenated ether in a molar ratio of 1:1 or 2:1 or 3:1, is new. Independent claims are included for: (1) the preparation of (A); and (2) a pharmaceutical formulation that is liquid or solid under normal conditions, comprising (A). ACTIVITY : Anesthetic; Analgesic. MECHANISM OF ACTION : None given. Die vorliegende Erfindung betrifft einen Komplex bestehend aus einem Cyclodextrin oder Cyclodextrinderivat und einem niedermolekularen halogeniertem Ether im molaren Verhältnis 1:1 oder 2:1 oder 3:1.